SCHEMBL382042

SCHEMBL382042

CC(C)(C)N(C(=O)O)C(CNS(C)(=O)=O)c1ccccc1C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 2/20 0.40
MMP7 P09237 1/20 0.38
ACP3 P15309 1/20 0.35
ALDH1A1 P00352 2/20 0.35
RORC P51449 1/20 0.35
POLB P06746 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
RAB9A P51151 1/20 0.34
MC4R P32245 1/20 0.34
ESR1 P03372 1/20 0.34
NR3C1 P04150 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD11B1 P28845 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL382150 0.90 CNR2 (0.39) CNR2MMP7ACP3ALDH1A1POLB
SCHEMBL19244870 0.84 CNR2 (0.40) CNR2ACP3ALDH1A1RORCPOLB
SCHEMBL19244867 0.83 OPRM1 (0.42)
SCHEMBL382428 0.81 ACP3 (0.43) CNR2ACP3ALDH1A1POLBTDP1
SCHEMBL167206 0.80 CNR2 (0.42) CNR2ACP3ALDH1A1POLBTDP1
SCHEMBL19244866 0.79 CNR2 (0.41) CNR2ACP3ALDH1A1POLBTDP1
SCHEMBL380984 0.79 CNR2 (0.41) CNR2ACP3ALDH1A1POLBTDP1
SCHEMBL380995 0.79 KMT2A (0.36) MEN1KMT2AHSD11B1
SCHEMBL380987 0.77 ALDH1A1 (0.40) MMP7ACP3ALDH1A1POLBL3MBTL1
SCHEMBL19244827 0.76 CNR2 (0.39) CNR2ACP3ALDH1A1POLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408751-B1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof BAYER IP GMBH (DE) 2017-08-23 EP disclosed
EP-2408751-A1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof Bayer Pharma Aktiengesellschaft (DE) 2012-01-25 EP disclosed
WO-2010105770-A1 SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-09-23 WO disclosed